Pages that link to "Q34313966"

The following pages link to Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein (Q34313966):

Displayed 50 items.

• Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein (Q22010970) ‎ (← links)
• MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells (Q24290823) ‎ (← links)
• The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein (Q24291005) ‎ (← links)
• Differential localization of HDAC4 orchestrates muscle differentiation (Q24291565) ‎ (← links)
• Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor (Q24299628) ‎ (← links)
• Isolation and identification of the human homolog of a new p53-binding protein, Mdmx (Q24318228) ‎ (← links)
• Regulation of E2A activities by histone acetyltransferases in B lymphocyte development (Q24318924) ‎ (← links)
• Regulation of cellular response to oncogenic and oxidative stress by Seladin-1 (Q24319120) ‎ (← links)
• Mdm2 promotes the rapid degradation of p53 (Q24322597) ‎ (← links)
• A cellular repressor of E1A-stimulated genes that inhibits activation by E2F (Q24329027) ‎ (← links)
• The Mdm2 oncoprotein interacts with the cell fate regulator Numb (Q24522545) ‎ (← links)
• TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1 (Q24535032) ‎ (← links)
• Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation (Q24536285) ‎ (← links)
• Inhibition of E2F-mediated transcription by p202 (Q24561908) ‎ (← links)
• MDMX: a novel p53-binding protein with some functional properties of MDM2 (Q24561971) ‎ (← links)
• DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo (Q24622928) ‎ (← links)
• MDM2 regulates dihydrofolate reductase activity through monoubiquitination (Q24634031) ‎ (← links)
• Functional interaction between DP-1 and p53 (Q24648034) ‎ (← links)
• Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation (Q24673794) ‎ (← links)
• Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis (Q26774960) ‎ (← links)
• To live or let die - complexity within the E2F1 pathway (Q26862588) ‎ (← links)
• Structure and specificity of nuclear receptor-coactivator interactions (Q27765991) ‎ (← links)
• Regulation of p53 stability by Mdm2 (Q27860744) ‎ (← links)
• Mdm2 as a chromatin modifier (Q28073903) ‎ (← links)
• MDM2--master regulator of the p53 tumor suppressor protein (Q28138926) ‎ (← links)
• Physical and functional interactions of neuronal growth suppressor necdin with p53 (Q28144785) ‎ (← links)
• The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter (Q28255693) ‎ (← links)
• Retinoblastoma protein recruits histone deacetylase to repress transcription (Q28262144) ‎ (← links)
• Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1 (Q28346512) ‎ (← links)
• A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2 (Q28588691) ‎ (← links)
• Cyclin G recruits PP2A to dephosphorylate Mdm2 (Q28638418) ‎ (← links)
• A genetic approach to mapping the p53 binding site in the MDM2 protein (Q28758655) ‎ (← links)
• Regulation of peroxisome proliferator-activated receptor-alpha by MDM2. (Q29347007) ‎ (← links)
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 (Q29617850) ‎ (← links)
• A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility? (Q30321053) ‎ (← links)
• Therapeutic considerations for Mdm2: not just a one trick pony (Q30380490) ‎ (← links)
• A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity (Q30395176) ‎ (← links)
• A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNA (Q30433118) ‎ (← links)
• Identification of a CK2 phosphorylation site in mdm2. (Q30812794) ‎ (← links)
• HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy (Q31146456) ‎ (← links)
• The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth (Q33292242) ‎ (← links)
• Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy (Q33331908) ‎ (← links)
• Mdm2: the ups and downs (Q33594040) ‎ (← links)
• Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis (Q33601591) ‎ (← links)
• The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF). (Q33650001) ‎ (← links)
• Molecular interaction map of the mammalian cell cycle control and DNA repair systems (Q33704559) ‎ (← links)
• CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner (Q33744679) ‎ (← links)
• Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia (Q33747235) ‎ (← links)
• Regulation of E2F: a family of transcription factors involved in proliferation control (Q33751868) ‎ (← links)
• Regulation of p53 stability (Q33807793) ‎ (← links)